Prognostic and Predictive Factors in Patients with Advanced Penile Cancer Receiving Salvage (2nd or Later Line) Systemic Treatment: A Retrospective, Multi-Center Study

Metastatic penile squamous cell carcinoma (PSCC) is associated with dismal outcomes with median overall survival (OS) of 6-12 months in the first-line and

Saved in:
Bibliographic Details
Published in:Frontiers in pharmacology 2016-12, Vol.7, p.487-487
Main Authors: Buonerba, Carlo, Di Lorenzo, Giuseppe, Pond, Gregory, Cartenì, Giacomo, Scagliarini, Sarah, Rozzi, Antonio, Quevedo, Fernando J, Dorff, Tanya, Nappi, Lucia, Lanzetta, Gaetano, Pagliaro, Lance, Eigl, Bernhard J, Naik, Gurudatta, Ferro, Matteo, Galdiero, Mariano, De Placido, Sabino, Sonpavde, Guru
Format: Article
Language:English
Subjects:
cetuximab
chemotherapy
Penile Neoplasms
Pharmacology
Prognostic biomarkers
Squamous cell carcinoma
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Metastatic penile squamous cell carcinoma (PSCC) is associated with dismal outcomes with median overall survival (OS) of 6-12 months in the first-line and
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2016.00487